Device Trial Radar · NCT05357378
Safety and Effectiveness of the HIT Reverse HRS
Last checked: Nov 19, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
288
Planned (sponsor's estimate)
Start
Jul 15, 2022
Primary completion
Sep 16, 2030
Study completion Sep 16, 2038
Sponsor
- Lead sponsor
- Hip Innovation TechnologyNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 2, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 50 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if the use of the HIT Reverse Hip Replacement System is safe and effective in patients undergoing total hip replacement. We will determine whether it is safe and effective by comparing it to the control devices.
Conditions
- Degenerative Joint Disease
- Osteoarthritis, Hip
- Avascular Necrosis of Hip
- Traumatic Arthropathy-Hip
Interventions
Hip Innovation Technology Reverse Hip Replacement SystemDevice
Implantation of the Investigational Device is performed using standard surgical procedures for THA, as described in the Instructions for Use (IFU). The control hip systems will be implanted in accordance with their respective IFU, which are also in line with standard surgical approaches for THA.
Already-marketed semi-constrained uncemented hip systems using a metal-on-XLPE or ceramic-on-XLPE bearing combination.Device
Control Arm subjects will receive one of the already-marketed semi-constrained uncemented hip systems using a metal-on-XLPE or ceramic-on-XLPE bearing combination. * DePuy Synthes CORAIL® or DePuy Synthes ACTIS™ Total Hip System in combination with DePuy Synthes PINNACLE™Complete Acetabular Hip System. * Zimmer Biomet Taperloc®, Zimmer Z1™ Cementless Femoral Hip Stem System or Zimmer Biomet AVENIR® Complete Hip System in combination with Zimmer Biomet G7® Acetabular System. * Stryker Accolade® II femoral stem in combination with Stryker Trident® II acetabular cup. * Smith \& Nephew ANTHOLOGY® Total Hip System in combination with Smith \& Nephew R3® Acetabular System
Primary outcomes
What the sponsor says the trial is designed to measure.
- OHS of 36 or more at the 2-year follow-up visitTime frame: 24 months
- Change in OHS of 12 or more at the 2-year follow-up visit compared to baseline.Time frame: 24 months
- Radiologic success at the 2-year follow-upTime frame: 24 months
1 more outcomes with a free account
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Miami Institute for Joint Reconstruction
Miami, Florida · Recruiting
Advent Health Hospital, Carrollwood
Tampa, Florida · Recruiting
Tampa General Health / Florida Orthopedic Institute
Tampa, Florida · Recruiting
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.